It was observed that, despite virtually all CLL cells could degrade ADP to AMP as they constitutively express CD39, a certain proportion of cells expressing CD73 is needed to appreciate ADO production, with a cut-off of ≥30% positive cells. Here, NT5E is linked to B-cell chronic lymphocytic leukemia.